Left ventricular aneurysm medical therapy

Left ventricular aneurysm Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Left ventricular aneurysm from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Left ventricular aneurysm medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Left ventricular aneurysm medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Left ventricular aneurysm medical therapy
CDC on Left ventricular aneurysm medical therapy
Left ventricular aneurysm medical therapy in the news
Blogs on Left ventricular aneurysm medical therapy
Directions to Hospitals Treating Left ventricular aneurysm
Risk calculators and risk factors for Left ventricular aneurysm medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Overview

Afterload reduction and treatment anginal pain are the main stay of medical therapy for small and medium size LV aneurysms.

Medical Therapy

Medical therapy is indicated for small and medium sized LV aneurysms. It is based on decreasing cardiac work load (afterload reduction), anti ischemic therapy for chest pain and anti coagulation if mural thrombosis exist.

• Afterload reduction:

ACE inhibitors are the drug of choice for decreasing the afterload.

• Anti ischemic therapy:

Many medications can be used to treat underlying ischemic event as well as decreasing ischemic burden including:

Nitrates | Beta Blockers | Calcium Channel Blockers | Potassium Channel Openers | Newer Anti-anginal Agents